Historical Milestones in Reperfusion Therapy for Myocardial Infarction

Reperfusion Therapy for Acute Myocardial Infarction

Volumn , Issue , 2016, Pages 1-14

  Braunwald, Eugene ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872080909     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (58)

1. Osler W. The Principles and Practice of Medicine. New York: D. Appleton, 1892.
2. Krehl L. Die Ekrankungen des Herzmuskels und die Nervosen Herzkrankheiten. Vienna: Alfred Holder, 1901.
3. Obraztov VP, Strazhesko ND. Simptomatiologii I diagnostike tromboza venecchinikh arteril cerdtsa. In: Vorobeva VA, Konchalovski MP, eds. Trudi pervogo sesda rossushkikh terapevtov. Vol 10. Moscow: Tovareschejestvo Tepografre, A.E. Mamontov, 1910:26-43 (Russian).
4. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912; 59:2015-2022.
5. Friedberg K, Horn H. Acute myocardial infarction not due to coronary artery occlusion. JAMA 1939; 112:1675-1679.
6. Branwood AW, Montgomery GL. Observations on the morbid anatomy of coronary artery disease. Scot Med J 1956; 1:367-375.
7. Roberts WC. Coronary thrombosis and fatal myocardial ischemia. Circulation 1974; 49:1-3.
8. Rentrop KP. Development and pathophysiological basis of thrombolytic therapy in acute myocardial infarction: Part I. 1912-1977-The controversy over the pathogenetic role of thrombus in acute myocardial infarction. J Intervent Cardiol 1998; 11:255-263.
9. Rentrop KP, Blanke H, Karsch KR, et al. Koronarmorphologie und linksventrikulaere. Pumpfunktion im akuten Infarktstadium und ihre Aenderungen im chronischem Stadium. Z Kardiol 1979; 68:335-350.
10. DeWood M, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303:898-902.
11. Rentrop KP, Blanke H, Wiegand V, et al. Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase in combination with transluminal recanalization. Clin Cardiol 1979; 2:354-363.
12. Tennant R, Wiggers CJ. The effect of coronary occlusion on myocardial contraction. Am J Physiol 1935; 112:351-361.
13. Blumgart L, Gilligan R, Schlesinger MJ. Experimental studies on the effect of temporary occlusion of coronary arteries. II. The production of myocardial infarction. Am Heart J 1941; 22:374-389.
14. Julian DG. Treatment of cardiac arrest in acute myocardial ischemia and infarction. Lancet 1961; 11:840-844.
15. Braunwald E, Covell JW, Maroko PR, Ross J Jr. Effect of drugs and of counterpulsation on myocardial oxygen consumption. Circulation 1969; 40(suppl 4):220-228.
16. Maroko PR, Kjekshus JK, Sobel E, et al. Factors influencing infarct size following experimental coronary artery occlusion. Circulation 1971; 43:67-82.
17. Braunwald E. Control of myocardial oxygen consumption: Physiologic and clinical considerations. Am J Cardiol 1971; 27:416-432.
18. Ginks WR, Sybers PR, Maroko PR, et al. Coronary artery reperfusion. II. Reduction of myocardial infarct size at one week after the coronary occlusion. J Clin Invest 1972; 51:2717-2723.
19. Maroko PR, Braunwald E. Modification of myocardial infarction size after coronary occlusion. Ann Intern Med 1973; 79:720-733.
20. Reimer KA, Lower JE, Rasmussen MM, et al. The wavefront phenomenon of ischemic cell death. I. Myocardial infarct size vs. duration of coronary occlusion in dogs. Circulation 1977; 56:786-794.
21. Tillet W, Garner R. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58:485-502.
22. Tillet W, Sherry S, Read C. The use of streptokinase-streptodornase in the treatment of chronic empyema. J Thorac Surg 1951; 21:325-341.
23. Tillett WS, Johnson AJ, McCarty WR. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest 1955; 34:169-185.
24. Fletcher AP, Sherry S, Alkjaersig H, et al. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest 1959; 38:1111-1119.
25. Yusuf S, Collins R, Peto R, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and sideeffects from 33 randomized controlled trials. Eur Heart J 1985; 6:556-585.
26. European Cooperative Study Group. Streptokinase in acute myocardial infarction. N Engl J Med 1979; 301:797-802.
27. Chazov EI, Mateeva LS, Mazaev AV. Intracoronary administration of fibrinolysin in acute myocardial infarction. Ter Arkh 1976; 48:8-19.
28. Rentrop P, Blanke H., Karsch KR, et al. Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 1981; 63:307-317.
29. Markis JE, Malagold M, Parker JA, et al. Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction: assessment of intracoronary thallium-201. N Engl J Med 1981; 305:777-782.
30. Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256:7035-7041.
31. Van de Werf F, Ludbrook PA, Berhmann SR, et al. Coronary thrombolysis with tissuetype plasminogen activator in patients with evolving myocardial infarction. N Engl J Med 1984; 310:609-613.
32. Pennica D, Holmes WE, Kohr WJ, et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301:214-221.
33. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 1985; 312:932-936.
34. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) Trial. Circulation 1987; 75:817-829.
35. Dalen JE, Gore JM, Braunwald E, et al. Six and twelve-month follow-up of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial. Am J Cardiol 1988; 62:179-185.
36. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397-402.
37. Fanzosi MG, Santoro E, De Vita C, et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sobrevivenza nell’Infarto-1 Study. Circulation 1998; 98: 2659-2665.
38. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 1:349-360.
39. Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994; 343:311-322.
40. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-682.
41. The GUSTO Angiographic Investigators. The comparative effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-1622.
42. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs. hospitalinitiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270:1211-1216.
43. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329:383-389.
44. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005; 352:1179-1189.
45. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45, 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366:1607-1621.
46. Sabatine MS, Morrow DA, Montalescot G, et al. Angiographic and clinical outcomes in patients receiving low-molecular weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 trial. Circulation 2005; 112:3846-3854.
47. Cheanvechai C, Effler DB, Loop FD, et al. Emergency myocardial revascularization. Am J Cardiol 1973; 32:901-908.
48. Berg R, Everhart FJ, Duvoisin G, et al. Operation for acute coronary occlusion. Am Surg 1976; 42:517-521.
49. Gruntzig A. Transluminal dilatation of coronary artery stenosis. Lancet 1978; 1:263.
50. Rentrop KP, Blanke H, Karsch KR, et al. Initial experience with transluminal recanalization of the recently occluded infarct-related coronary artery in acute myocardial infarction-comparison with conventionally treated patients. Clin Cardiol 1979; 2:92-105.
51. Meyer J, Merx W, Dorr R, et al. Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary revascularization (PTCR) and percutaneous coronary angioplasty (PTCA). Am Heart J 1982; 103:132-134.
52. Papapietro SE, MacLean WAH, Stanley AWH Jr, et al. Percutaneous transluminal coronary angioplasty in acute myocardial infarction. J Am Coll Cardiol 1983; 1:580.
53. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Group. N Engl J Med 1993; 328:673-679.
54. GUSTO IIb Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 1997; 336:1621-1628.
55. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet 2003; 361:13-20.
56. Zhu MM, Feit A, Chadow H, et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction. A meta analysis of randomized clinical trials. Am J Cardiol 2001; 88:297-301.
57. Lane GE, Holmes DR Jr. Primary percutaneous coronary intervention in the management of acute myocardial infarction. In: Zipes DR, Libby P, Bonow RO, et al., eds. Braunwald’s Heart Disease. 7th ed. Philadelphia: WB Saunders, 2005:1227-1240.
58. Antman EM, Anbe DT, Armstrong P.W, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004; 44:671-719.